Biofrontera Newderm

Biofrontera Newderm is a specialized biopharmaceutical company focused on dermatology, particularly the development and commercialization of photodynamic therapy (PDT) for non-melanoma skin cancer. Originally established as a subsidiary of Biofrontera AG, the company was fully acquired by the Japanese pharmaceutical firm Maruho in December 2023. Its core business revolves around Ameluz, a topical gel containing aminolevulinic acid, which is used alongside specialized LED lamps to treat actinic keratosis and other skin conditions. The company continues to support the clinical expansion and commercialization of these dermatological treatments globally.